A cross‐sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor‐derived DNA with CEA for detection of recurrent colorectal cancer

Recurrence will develop in 30–50% of colorectal cancer (CRC) cases despite apparent clearance following treatment. Carcinoembryonic antigen (CEA) is the only guideline‐recommended blood test for monitoring cases for recurrence, but its sensitivity and specificity are suboptimal. This observational s...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Graeme P., Pedersen, Susanne K., Mansfield, Scott, Murray, David H., Baker, Rohan T., Rabbitt, Philippa, Byrne, Susan, Bambacas, Libby, Hollington, Paul, Symonds, Erin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083729/
https://www.ncbi.nlm.nih.gov/pubmed/27726312
http://dx.doi.org/10.1002/cam4.868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083729/
https://www.ncbi.nlm.nih.gov/pubmed/27726312
http://dx.doi.org/10.1002/cam4.868

Ejemplares similares